Although increased Fak activity in cancer cells is thought to drive Erk activity and proliferation, a number of studies have indicated that Erk can directly regulate focal adhesion turnover, at least in part by phosphorylation of Fak [30, 43]. The gene discussed is PTK2; the disease is cancer.